IDiyas

For the Inventor, By the Inventor

Bethesda, MD, United States of America

Anton Simeonov

USPTO Granted Patents = 25 

 

Average Co-Inventor Count = 9.3

ph-index = 3

Forward Citations = 30(Granted Patents)


Location History:

  • Santa Cruz, CA (US) (2019)
  • Rockville, MD (US) (2017 - 2021)
  • Bethesda, MD (US) (2014 - 2024)

Company Filing History:

goldMedal21 out of 3,435 
 
National Institutes of Health, a Component of the US Dept. of Health & Human Services
 patents
silverMedal6 out of 1,153 
 
Vanderbilt University
 patents
bronzeMedal6 out of 580 
 
The Uab Research Foundation
 patents
4. 6 out of 2,595 
 
University of Pennsylvania
 patents
5. 4 out of 15,458 
 
University of California
 patents
6. 3 out of 1,926 
 
University System of Maryland
 patents
7. 3 out of 72 
 
Children's National Medical Center
 patents
8. 3 out of 50 
 
Eastern Virginia Medical School
 patents
9. 3 out of 528 
 
Thomas Jefferson University
 patents
10. 3 out of 516 
 
Beth Israel Deaconess Medical Center, Inc.
 patents
11. 2 out of 2 
 
The United States of America Department of Health
 patents
12. 2 out of 1,269 
 
University of North Carolina at Chapel Hill
 patents
13. 1 out of 1 
 
Elias Set Jenö Arnér
 patent
14. 1 out of 430 
 
University of Delaware
 patents
15. 1 out of 1,325 
 
Yale University
 patents
16. 1 out of 25 
 
Children's Hospital
 patents
17. 1 out of 1 
 
The United States of America,as Represented by the Secretary, Department of Health and Human Servic
 patent
18. 2 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 2014-2025

Loading Chart...
Loading Chart...
25 patents (USPTO):
1. 12365653 - Small molecule inhibitors of lactate dehydrogenase and methods of use thereof (2025-07-22),
2. 11897845 - Small molecule inhibitors of lactate dehydrogenase and methods of use thereof (2024-02-13),
3. 11795177 - Substituted quinoline analogs as aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors (2023-10-24),
4. 11505559 - Substituted quinoline analogs as aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors (2022-11-22),
5. 11274077 - 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase (2022-03-15),
6. 11247971 - Small molecule inhibitors of lactate dehydrogenase and methods of use thereof (2022-02-15),
7. 11129835 - Methods and compositions for the inhibition of PIN1 (2021-09-28),
8. 11110089 - Pyridazinones and their use in the treatment of cancer (2021-09-07),
9. 10961200 - Small molecule inhibitors of lactate dehydrogenase and methods of use thereof (2021-03-30),
10. 10954228 - 1 H-pyrazol-1-yl-thiazoles as inhibitors of lactate dehydrogenase and methods of use thereof (2021-03-23),
11. 10899710 - Pyridines and their use in the treatment of cancer (2021-01-26),
12. 10881653 - Tricyclic compounds and their use in the treatment of cancer (2021-01-05),
13. 10836759 - Thiazole derivatives useful as mutant IDH1 inhibitors for treating cancer (2020-11-17),
14. 10752581 - 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase (2020-08-25),
15. 10703746 - Mutant IDH1 inhibitors useful for treating cancer (2020-07-07),

Title: Anton Simeonov: Pioneering Inventor from Bethesda

Introduction: Anton Simeonov is a renowned inventor based in Bethesda, MD, known for his groundbreaking contributions to the field of innovation and patents.

Latest Patents: Anton Simeonov holds several patents in various industries, showcasing his versatility and ingenuity in creating novel solutions to complex problems.

Career Highlights: With a career spanning over two decades, Anton Simeonov has established himself as a leading figure in the world of inventions. His work has not only revolutionized existing technologies but has also paved the way for new advancements in the field.

Collaborations: Throughout his career, Anton Simeonov has collaborated with top research institutions, universities, and companies to bring his inventions to life. His ability to work across disciplines has led to the development of cutting-edge technologies with real-world applications.

Conclusion: In conclusion, Anton Simeonov's passion for innovation and his relentless pursuit of excellence have solidified his position as a trailblazer in the world of inventions. His work continues to inspire future generations of inventors and researchers to push the boundaries of what is possible.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…